ImpediMed Limited is an Australia-based medical software technology company. The Company develops various medical products that uses bioimpedance spectroscopy (BIS) technologies for use in the noninvasive clinical assessment and monitoring of fluid status and tissue composition. The Company develops, manufactures and sells BIS devices and software services with a focus on the early detection of lymphoedema and heart failure. Its product includes SOZO Digital Health Platform, which is a non-invasive BIS device that delivers a snapshot of fluid status and tissue composition in approximately 30 seconds. SOZO Applications include various software applications, such as L-Dex Analysis for Lymphedema, Body Composition Analysis, Segmental Analysis and HF-Dex Analysis for Heart Failure. Its research devices include SFB7 and ImpediVET. SFB7 single channel, tetrapolar BIS device, which measures fluid status and tissue composition for clinical and research applications.